| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 405,8 k € | — | — | — | ||||||||||||||||||
| Gross margin | 369,0 k € | +12.3% | 328,7 k € | +94.3% | 169,1 k € | +20.2% | 140,8 k € | -35.4% | 218,0 k € | +16.1% | 187,7 k € | -13.7% | 217,4 k € | -40.4% | 364,7 k € | +16.0% | 314,4 k € | -9.0% | 345,6 k € | +29.9% | 266,0 k € | -9.0% | 292,4 k € | -20.1% | 366,0 k € | -7.6% | 395,9 k € | -2.4% | 405,8 k € | +13.6% | 357,2 k € | +29.1% | 276,8 k € | +15.3% | 240,1 k € | |
| EBITDA | 170,8 k € | +23.6% | 138,2 k € | +1277.4% | 10,0 k € | -78.9% | 47,6 k € | -35.3% | 73,6 k € | +873.1% | 7,6 k € | -79.2% | 36,4 k € | -80.8% | 189,6 k € | +61.9% | 117,1 k € | -35.6% | 181,9 k € | +68.1% | 108,2 k € | -23.0% | 140,5 k € | -28.6% | 196,7 k € | -11.1% | 221,3 k € | -5.2% | 233,4 k € | +19.8% | 194,9 k € | +146.1% | 79,2 k € | +5.2% | 75,3 k € | |
| Operating profit | 99,8 k € | +49.0% | 67,0 k € | +223.8% | -54,1 k € | -340.4% | 22,5 k € | -54.1% | 49,0 k € | +389.0% | -17,0 k € | -255.0% | 10,9 k € | -93.0% | 155,6 k € | +73.7% | 89,6 k € | -45.3% | 163,8 k € | +79.4% | 91,3 k € | -25.3% | 122,2 k € | -25.5% | 164,0 k € | +0.0% | 163,9 k € | -6.7% | 175,7 k € | +24.1% | 141,5 k € | +420.5% | 27,2 k € | +32.4% | 20,5 k € | |
| Profit/loss | 74,2 k € | +51.6% | 48,9 k € | +190.0% | -54,4 k € | -313.0% | 25,5 k € | -39.4% | 42,2 k € | +572.8% | -8,9 k € | -169.9% | 12,7 k € | -88.5% | 111,1 k € | +72.5% | 64,4 k € | -45.8% | 118,7 k € | +62.3% | 73,1 k € | -23.5% | 95,6 k € | -20.4% | 120,2 k € | +3.0% | 116,7 k € | -7.4% | 126,0 k € | +17.4% | 107,4 k € | +363.5% | 23,2 k € | +3.9% | 22,3 k € | |
| Equity | 1,1 M € | +7.4% | 1,0 M € | +5.1% | 959,0 k € | -34.2% | 1,5 M € | +1.8% | 1,4 M € | +3.0% | 1,4 M € | -0.6% | 1,4 M € | +0.9% | 1,4 M € | +8.7% | 1,3 M € | +5.3% | 1,2 M € | +10.9% | 1,1 M € | +7.2% | 1,0 M € | +10.4% | 922,9 k € | +15.0% | 802,8 k € | +17.0% | 686,1 k € | +22.5% | 560,0 k € | +23.7% | 452,6 k € | -17.6% | 549,5 k € | |
| Total assets | 1,2 M € | +6.2% | 1,2 M € | -2.3% | 1,2 M € | -28.8% | 1,7 M € | +5.5% | 1,6 M € | +4.1% | 1,5 M € | -1.9% | 1,6 M € | +0.6% | 1,6 M € | +8.2% | 1,4 M € | +3.3% | 1,4 M € | +7.5% | 1,3 M € | +5.2% | 1,2 M € | +12.4% | 1,1 M € | +4.7% | 1,0 M € | +4.8% | 1,0 M € | +25.5% | 797,1 k € | -1.9% | 812,2 k € | -0.9% | 819,6 k € | |
| Cash | 4,7 k € | -11.0% | 5,3 k € | -31.0% | 7,7 k € | +28.9% | 6,0 k € | -33.4% | 9,0 k € | -14.5% | 10,5 k € | +46.9% | 7,2 k € | -34.7% | 11,0 k € | -37.3% | 17,5 k € | -63.5% | 48,1 k € | +6.8% | 45,0 k € | +22.6% | 36,7 k € | +6.8% | 34,4 k € | +22.9% | 28,0 k € | -34.2% | 42,5 k € | -82.1% | 238,0 k € | +28.0% | 185,9 k € | +105.9% | 90,3 k € | |
| Debts | 165,3 k € | -0.6% | 166,3 k € | -31.7% | 243,4 k € | +4.8% | 232,2 k € | +37.0% | 169,5 k € | +14.0% | 148,7 k € | -12.6% | 170,1 k € | -1.9% | 173,4 k € | +4.1% | 166,5 k € | -10.0% | 185,1 k € | -10.2% | 206,2 k € | -4.2% | 215,3 k € | +23.1% | 174,9 k € | -28.8% | 245,7 k € | -21.8% | 314,1 k € | +32.5% | 237,1 k € | -34.1% | 359,6 k € | +33.5% | 269,4 k € | |
| Staff | 3 | 3,3 | 3,1 | 2,1 | 2,2 | 3,1 | 2,5 | 3,1 | 3,1 | 3,5 | 3,4 | 3,1 | 3,4 | 3,9 | 3,4 | 3,3 | 4,1 | 3,8 | ||||||||||||||||||
Private limited company · De Haan · incorporated on 28/12/1983 · 3,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-11.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
WENDUINE PHARMA is a Private limited company incorporated in 1983. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in De Haan. It employs on average 3,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette